Early Phase 1 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had preeclampsia (a pregnancy complication involving high blood pressure) within the past 5 years
- People who are 18 years of age or older
Who may not be able to join:
- People who currently take aspirin every day
- People who have a skin disease or skin condition
- People who currently use tobacco or nicotine in any form, including vaping
- People who have been diagnosed with, or are suspected to have, a liver disease, metabolic disease, or chronic kidney disease (defined by a specific kidney function measurement being below a certain level — confirm with trial site)
- People who currently take statins or any other medication to lower cholesterol
- People who currently take medication to lower blood pressure
- People who had high blood pressure before any pregnancy
- People who have a history of gestational diabetes (diabetes during pregnancy)
- People who are currently pregnant
- People whose body weight is considered underweight based on a standard height-to-weight measurement (confirm with trial site)
- People who have an allergy to materials that may be used during the study, such as latex
- People who have known allergies to the medications being studied
- People who have bleeding disorders, stomach ulcers, inflammation of the stomach lining, gastrointestinal bleeding, or acid reflux disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 319-467-1732
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
magnitude of microvascular endothelial function; magnitude of brachial artery endothelial function; magnitude of microvascular endothelin-1 mediated constriction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.